Bluejay Diagnostics
BJDX
2 hedge funds and large institutions have $99.8K invested in Bluejay Diagnostics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
109% more capital invested
Capital invested by funds: $47.8K → $99.8K (+$52K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less funds holding
Funds holding: 4 → 2 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$122K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.41K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$13K |
| 2 |
HF
HRT Financial
New York
|
-$8K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.86K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$7.12K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.18K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $91.9K | +$122K | +13 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $6.24K | +$9.41K | +1 | New |
|
3
JP Morgan Chase
New York
| $914 | – | – | – |
|
|
CAS
4
Coppell Advisory Solutions
Coppell,
Texas
| $674 | – | – | – |
|
5
Osaic Holdings
Scottsdale,
Arizona
| $108 | – | – | – |
|
6
Wells Fargo
San Francisco,
California
| $17 | – | – | – |
|
|
7
Renaissance Technologies
New York
| – | -$13K | -2 | Closed |
|
|
8
Geode Capital Management
Boston,
Massachusetts
| – | -$7.86K | -1 | Closed |
|
|
HF
9
HRT Financial
New York
| – | -$8K | -1 | Closed |
|
|
TSS
10
Two Sigma Securities
New York
| – | -$7.12K | -1 | Closed |
|
11
Northern Trust
Chicago,
Illinois
| – | -$3.08K | – | – |
|
12
UBS Group
Zurich,
Switzerland
| – | -$1.36K | – | – |
|
|
13
Vanguard Group
Malvern,
Pennsylvania
| – | -$4.18K | – | – |
|
BJDX Hedge Fund Activity: Q3 2023 in Review
2 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Bluejay Diagnostics (BJDX) for Q3 2023, worth a combined $99.8K — up 109% from $47.8K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BJDX and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $122K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $13K sold.
- 2 institutional investors held Bluejay Diagnostics (BJDX) as of Q3 2023, down from 4 in Q2 2023.
- Funds reported $99.8K of Bluejay Diagnostics stock for Q3 2023, up 109% quarter-over-quarter.
- 2 funds opened new Bluejay Diagnostics positions in Q3 2023 and 4 closed out, a net change of -2 holders.
- The largest Bluejay Diagnostics buyer in Q3 2023 was Sabby Management, an estimated $122K added.
- The largest Bluejay Diagnostics seller in Q3 2023 was Renaissance Technologies, an estimated $13K sold.
Based on aggregated 13F filings for Q3 2023.